IP Library Granted Patent US 8,686,126
Granted Patent B2
US 8,686,126 · App. 13/553,214 · Granted Apr 1, 2014

HBV drug resistance methods

Inventor: Abdurrahman Mithat Bozdayi (Golbasi-Ankara, TR)
Assignee: Innogenetics N.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,686,126
App. No.
13/553,214
Granted
Apr 1, 2014
Kind
B2
Abstract

New polymorphisms in the nucleic acid sequences of the DNA polymerase/reverse transcriptase open reading frame and viral surface antigen open reading frame of the hepatitis B virus are reported. In particular, the present invention relates to the mutation YMDD→YSDD in the HBV reverse transcriptase domain and to the W196V mutation in the small HBV viral surface antigen. Said polymorphisms are affecting the detection of drug resistance mutations by genotypic methods and diagnostic kits based thereon. The present invention relates to methods and diagnostic kits for detection of a HBV virus comprising said nucleic acid polymorphisms. In particular, those methods utilizing oligonucleotides capable of hybridizing to said HBV nucleic acid polymorphisms are envisaged.

Claims (6)

1. A diagnostic kit for detecting resistance to lamivudine or a combination of antiviral drugs comprising lamivudine of an HBV virus present in a biological sample comprising an oligonucleotide capable of discriminating, in said HBV polynucleic acid, a codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4) encoding a serine from a codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4) encoding a methionine, valine or isoleucine.

2. The diagnostic kit according to claim 1 further comprising an oligonucleotide capable of discriminating, in said HBV polynucleic acid, a codon at the position corresponding to position 180 of sequence P7RT (position 84 of SEQ ID NO:4) encoding a methionine from a codon at the position corresponding to position 180 of sequence P7RT (position 84 of SEQ ID NO:4) encoding a leucine.

3. The diagnostic kit according to claim 1 wherein said oligonucleotide is attached or immobilized to a solid support.

4. The diagnostic kit according to claim 2 wherein at least one of

said oligonucleotide capable of discriminating, in said HBV polynucleic acid, a codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4) encoding a serine from a codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4) encoding a methionine, valine or isoleucine is attached or immobilized to a solid support and

said oligonucleotide capable of discriminating, in said HBV polynucleic acid, a codon 180 encoding a methionine from a codon 180 encoding a leucine is attached or immobilized to a solid support.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2014
From: BOZDAYI, ABDURRAHMAN MITHAT
To: INNOGENETICS N.V.
Reel/Frame 033707/0408 →
CHANGE OF NAME Recorded Sep 10, 2014
From: INNOGENETICS N.V.
To: FUJIREBIO EUROPE N.V.
Reel/Frame 033709/0234 →
Continuity (2)
Continuation 10509094
Related Publication 20130040284A1 · Feb 14, 2013